Thiazide induced acute pulmonary edema. Report of one case;Edema pulmonar agudo por uso de tiazidas, ¿existe falla cardíaca? Comunicación de un caso

Revista Medica de Chile

Volumn 135, Issue 4, 2007, Pages 496-500

  Andresen H, Max ^a   González M, Alejandro ^a   Espino E, Alberto ^a   Mercado F , Marcelo ^a   Regueira H , Tomas ^a   Dougnac L, Alberto ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Natriuretic peptide type B; Pulmonary edema; Thiazides

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; HYDROCHLOROTHIAZIDE;

ACUTE DISEASE; ARTICLE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; LUNG EDEMA; MIDDLE AGED;

ACUTE DISEASE; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PULMONARY EDEMA;

EID: 34249034344     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. BERNARD GR, ARTIGAS A, KENNETH L, BRIGHAM KL, CARLET J, FALKE K ET AL. Report of The American-European consensus Conference on Acute Respiratory Distress Syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Crit Care 1994; 9: 72-81.
2. RUBENFELD G, CALDWELL E, PEABODY E, WEAVER J, MARTIN D, NEFF M ET AL. Incidence and Outcomes of Acute Lung Injury. N Engl J Med 2005; 353: 1685-93.
3. REED CR, GLAUSER FL. Drug-induced noncardiogenic pulmonary edema. Chest 1991; 100: 1120-4.
4. STEINBERG AD. Pulmonary edema following ingestion of hydrochlorothiazide. JAMA 1968; 204: 167-8.
5. SALDAÑA A, JALIL J, GAETE P, FAJURI A, CASTRO P, GODOY I ET AL. Edema pulmonar no cardiogénico relacionado con la hidroclorotiazida. Rev Méd Chile 1996; 124: 720.
6. FRIERSON JH, MARVEL SL, THOMAS GM. Hydrochlorothiazide -induced- pulmonary edema with severe acute myocardial dysfunction. Clin Cardiol 1995; 18: 112-4.
7. MACLEAN A, HUANG S. The applications of B-type natriuretic peptide measurement in the intensive care unit. Curr Opin Crit Care 2005; 11: 406-12.
8. BIN YAP L, MUKERJEE D, TIMMS PM, ASHRAFIAN H, COGHLAN JG. Natriuretic Peptides, Respiratory Disease, and the Right Heart. Chest 2004; 126: 1330-6.
9. KNOWLES SR, WONG GA, RAHIM SA, BINKLEY K, PHILLIPS EJ, SHEAR NH. Hydrochlorothiazide-induced noncardiogenic pulmonary edema: an underrecognized yet serious adverse drug reaction. Pharmacotherapy 2005; 25: 1258-65.
10. FINE SR, LODHA A, ZONERAICH S, MOLLURA JL. Hydrochlorothiazide induced acute pulmonary edema. Ann Pharmacother 1995; 29: 701-3.
11. MAS A, JORDANA R, VALLÉS J, CERVANTES M. Recurrent hydrochlorothiazide-induced pulmonary edema. Intensive Care Med 1998; 24: 363-5.
12. BERNAL C, PATACA R. Hydrochlorothiazide-induced pulmonary edema and associated immunologic changes. Ann Pharmacother 1999; 33: 172-4.
13. CASTILLO C, NARANJO J, OSSA G. Síndrome cardiopulmonar por hantavirus en 21 adultos en la IX región de Chile. Rev Chil Infectol 2000; 17: 241-7.
14. PRUPAS HM, BROWN D. Acute idiosyncratic reaction to hydrochlorothiazide ingestion. West J Med 1983; 138: 101-2.
15. BAYES-GENIS A, BELLIDO-CASADO J, ZAPICO E, COTES C, BELDA J, LÓPEZ L ET AL. N-terminal pro-brain natriuretic peptide reflects pulmonary capillary leakage in patients with acute dyspnea. Am J Cardiol 2004; 94: 669-70.
16. GERBES A, DAGNINO L, NGUYEN T, NEMER M. Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in humans tissues. J Clin Endocrinol Metab 1994; 78: 1307-11.
17. PHUA J, KEANG LIM T, HOE LEE K. B-type natriuretic peptide: Issues for the intensivist and pulmonologist. Crit Care Med 2005; 33: 2094-103.
18. REED CR, GLAUSER FL. Drug-induced noncardiogenic pulmonary edema. Chest 1991; 100: 1120-4.
19. BIRON P, DESSUREAULT J, NAPKE E. Acute allergic interstitial pneumonitis induced by hydrochlorothiazide. Can Med Assoc J 1991; 145: 28-34.
20. JARA CHINARRO B, MIGUEL DIEZ J, GARCIA SATUE JL. Edema agudo de pulmón no cardiogénico secundario a hidroclorotiazida. Arch Bronconeumol 2003; 39: 91-3.